Monte Rosa Therapeutics 宣布临床供应协议,支持Mrt-2359联合阿帕鲁胺治疗转移性去势抵抗性前列腺癌的二期试验

美股速递
Mar 16

Monte Rosa Therapeutics 已签署一项临床供应协议,旨在支持其二期临床试验的推进。该试验将评估Mrt-2359与阿帕鲁胺联合用药方案,用于治疗转移性去势抵抗性前列腺癌。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10